Care Beyond cure | Dr Radha Munje | TEDxCivilLines

Quick Overview

Dr. Radha Munje argues that healthcare must move "Care Beyond Cure" by addressing long-term functional disability and social burdens resulting from diseases like Tuberculosis (TB) and COVID-19, emphasizing the need for rehabilitation, prevention strategies, empathy, and specialized care systems to restore patients' dignity and quality of life after initial survival.

Key Points: Survival from major diseases like TB and COVID-19 is not enough, as many patients face persistent breathlessness due to lung scarring and fibrosis. Post-infection lung disease (PTLD) affects 15-60% of TB survivors globally, representing a massive, often hidden, public health issue. The speaker highlights that breathing difficulties turn health issues into a significant "social problem" by increasing dependence and reducing productivity. Effective long-term care requires proactive measures like rehabilitation, prevention strategies (like vaccination), and specialized follow-up care via Chest Clinics. Globally, WHO reported 360 million COVID cases and 10.7 million new TB cases annually, illustrating the vast scale of potential post-infection issues. The goal must shift from merely treating the infection to restoring life to its fullest by addressing the functional damage and associated social costs.

Context: This TEDx talk, titled "Care Beyond Cure," is delivered by Dr. Radha Munje, identified as a Professor & Head of Respiratory Medicine and Vice President (2024-2026) of The Union Lung Health, South East Asia Region. The presentation challenges the conventional focus solely on curing acute diseases, using Tuberculosis (TB) and COVID-19 as primary examples to illustrate that long-term respiratory damage and resulting disability persist long after the pathogen is eradicated, creating a societal burden that requires a new paradigm of care.

Detailed Analysis

Dr. Radha Munje delivers a compelling argument that the medical focus on survival and cure is insufficient, especially for respiratory illnesses like TB and COVID-19. She uses the example of a 40-year-old man treated for TB two years prior, who, despite being declared cured, faces breathlessness equivalent to climbing Mount Everest just to walk 100 meters, illustrating permanent functional damage. She explains that the lungs 'remember disease' through scarring and fibrosis, which causes ongoing difficulty (dyspnea) and functional disability, even after the organism is gone. This persistent breathlessness is framed not just as a medical symptom but as a significant 'social problem' leading to lost productivity and increased dependence on family and caregivers. Citing statistics, she notes that 15-60% of TB survivors suffer from Post-Treatment Lung Disease (PTLD), with India bearing a burden of 2.6 million cases. She argues that if we cannot stop the progression of this damage, we must at least slow it down by implementing 'Care Beyond Cure.' This care model requires imagination and innovation, focusing on rehabilitation, prevention strategies like vaccination, specialized Chest Clinics, and a healthcare system built on empathy to ensure patients achieve a 'rightful way to live,' not just survival.